Stock Updates

Biogen Inc. (NASDAQ: BIIB) – Is this large market cap stock undervalued?

Biogen Inc. (NASDAQ: BIIB), is firmly in the large market cap category with market cap of 68047.71. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Biogen Inc. is 310.55 (with a change from open of -1.72%), this in conjunction with a target price of 344.61. Volume today has so far reached 1018100, with an average volume of about 1747.19. The GAP for this stock, is 0.46%.

The P/E ratio is 18.13, bringing the forward P/E to a value of 14.9. The current EPS for Biogen Inc., is 17.13, with a EPS growth for this year coming to a value of 24.00%. Performance has been interesting with performance year to date coming to 1.37%.

Looking further into the growth statistics for Biogen Inc., EPS is looking like it will grow 3.67% in the next year. Looking even further it is projected to be 8.57%. Quarter over quarter is 21.60% for EPS growth and for sales growth quarter over quarter it is 11.70%. Looking at past EPS growth statistics we see that for the past five years it has been 31.30%. Sales growth for the past five years has in fact been 17.90%.

Looking at the ownership, we see that the insider ownership is at 0.10% and institutional ownership is 88.40%. Shares outstanding is 219.12, while shares float is at a value of 218.5. Float short for Biogen Inc. is 0.99% and the short ratio is 1.23.

In terms of debt, long term debt/equity is 0.57, while the total debt/equity comes to 0.57. The ability to meet these debts, means that the current ratio is 3, and the quick ratio is 2.6. The most recent gross margin is 88.20% and their operating margin is 47.90%. The profit margin is 34.00%.

Biogen Inc. has seen returns on assets of 18.50%, and on investment, 23.50%. Return on equity is 36.60%. Price/Earnings to growth ratio is 2.11. Price/Sales ratio is at a value of 6.06, with Price/book ratio coming to 5.97 and Price/cash is 17.92, and finally Price/Free cash Flow is 21.16.

The simple moving averages are 1.75% and 12.56% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -6.92% and the 52 week low is 39.25%.

Biogen Inc. has a dividend yield of *TBA, with a current price of 310.55. The ability to pay this means the payout ratio is 0.00%. This is in an industry, Biotechnology, with equally high dividends from other companies in this sector, which it is Healthcare. Biogen Inc. is based in USA.

Performance in the Biotechnology industry means that Biogen Inc. has seen performance for the past week of -0.46%, with performance for the month coming to 1.44%. Looking at the data for the quarter it is at a value of 29.99%, and for the half year the performance is 11.62%. Volatility for this week is 1.80% and for the month this is 2.02%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment